Third-Party Payer Effect On Clinical Trials Still Difficult To Quantify
Executive Summary
Third-party payer policies appear to have an effect on clinical trial participation, but the impact "is difficult" to quantify, according to a draft report by Duke Evidence-Based Practice Center researchers prepared for the Agency for Healthcare Research and Quality